DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo

Celgene (NASDAQ: CELG)

company name or ticker

Celgene (CELG) to Report Q4 Earnings: What to Expect?

Nick's Picks 2016: Happily Overweight With Healthcare

The 1 Biotech Stock I Want to Own in 2016

This innovative biotech remains a great long-term buy this year, despite its recent volatility. Here's why.

Celgene Reveals Data on Second-Line Abraxane-Gemzar

Dynavax: Positive Catalysts Mounting For This Small Biotech Concern

Biotech String: Editas IPO Terms, Rooting for Shkreli in DC

3 Drugs Stocks Moving The Industry Upward

Will 2016 Be Celgene Corporation's Best Year Yet?

Celgene outperformed the broader market in 2015, but can the company deliver superior results once more in 2016?

The ABC's Of Big Biotech Investing

Jim Cramer Dishes On Microsoft, Gilead, TG Therapeutics & NY Community Bancorp